May 13, 2024 Experience Ventas $500 million senior notes offering We advised Ventas on its investment-grade debt offering
April 10, 2024 Experience Biodesix $55 million follow-on offering The common stock is listed on the Nasdaq Global Market
March 21, 2024 Experience Plug Power private exchange offer A total of $138.8 million aggregate principal amount of existing convertible senior notes were exchanged
March 12, 2024 Experience REGENXBIO $140 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Select Market
March 11, 2024 Experience Tyson Foods $1.5 billion senior notes offerings We advised Tyson Foods on its investment-grade notes offering
March 8, 2024 Experience Hamilton Lane $210 million follow-on offering The shares are listed on the Nasdaq Stock Market
March 5, 2024 Experience Perella Weinberg Partners $65 million follow-on offering The shares are listed on Nasdaq
February 27, 2024 Experience AbbVie $15 billion senior notes offering The investment-grade offering comprised seven tranches
February 23, 2024 Experience Bristol Myers Squibb $13 billion notes offering The investment-grade offering comprised nine tranches
February 21, 2024 Experience Prime Medicine $161 million stock and pre-funded warrants offering The common stock is listed on the Nasdaq Global Market